Skip to content

A-type voltage-gated potassium channel KCND2 (KCND2)

Homo sapiens — UniProt Q9NZV8

Gene: KCND2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

A-type voltage-gated potassium channel KCND2 (KCND2) is a protein from Homo sapiens identified by UniProt accession Q9NZV8, 630 residues long. MolForge cross-references it against 1 known binders and 163 disease associations.

  • UniProt accession: Q9NZV8; gene symbol KCND2.
  • Organism: Homo sapiens.
  • Length: 630 amino acids.
  • Top disease associations (Open Targets): multiple sclerosis, Myasthenia gravis and early myoclonic encephalopathy.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameA-type voltage-gated potassium channel KCND2
UniProt accessionQ9NZV8
GeneKCND2
OrganismHomo sapiens
Length630 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (163)

Diseases linked to this target (Open Targets).

  • multiple sclerosis · score 0.59
  • Myasthenia gravis · score 0.57
  • early myoclonic encephalopathy · score 0.52
  • small cell carcinoma · score 0.46
  • Muscle weakness · score 0.46
  • genetic disorder · score 0.45
  • secondary progressive multiple sclerosis · score 0.43
  • Global developmental delay · score 0.37
  • Seizure · score 0.37
  • anterior ischemic optic neuropathy · score 0.37

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9NZV8-F1alphafoldPREDICTED71.51—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9NZV8.

Amino-acid sequence (630 residues)

MAAGVAAWLP FARAAAIGWM PVASGPMPAP PRQERKRTQD ALIVLNVSGT RFQTWQDTLE RYPDTLLGSS ERDFFYHPET QQYFFDRDPD IFRHILNFYR TGKLHYPRHE CISAYDEELA FFGLIPEIIG DCCYEEYKDR RRENAERLQD DADTDTAGES ALPTMTARQR VWRAFENPHT STMALVFYYV TGFFIAVSVI ANVVETVPCG SSPGHIKELP CGERYAVAFF CLDTACVMIF TVEYLLRLAA APSRYRFVRS VMSIIDVVAI LPYYIGLVMT DNEDVSGAFV TLRVFRVFRI FKFSRHSQGL RILGYTLKSC ASELGFLLFS LTMAIIIFAT VMFYAEKGSS ASKFTSIPAA FWYTIVTMTT LGYGDMVPKT IAGKIFGSIC SLSGVLVIAL PVPVIVSNFS RIYHQNQRAD KRRAQKKARL ARIRAAKSGS ANAYMQSKRN GLLSNQLQSS EDEQAFVSKS GSSFETQHHH LLHCLEKTTN HEFVDEQVFE ESCMEVATVN RPSSHSPSLS SQQGVTSTCC SRRHKKTFRI PNANVSGSHQ GSIQELSTIQ IRCVERTPLS NSRSSLNAKM EECVKLNCEQ PYVTTAIISI PTPPVTTPEG DDRPESPEYS GGNIVRVSAL

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with KCND2?

The strongest Open Targets associations for KCND2 are multiple sclerosis, Myasthenia gravis, early myoclonic encephalopathy, small cell carcinoma and Muscle weakness.

How long is the KCND2 protein?

The Homo sapiens KCND2 protein (UniProt Q9NZV8) is 630 amino acids long.

Browse: Targets: K · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore A-type voltage-gated potassium channel KCND2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9NZV8
GeneKCND2
OrganismHomo sapiens
Length630
Binders1
Diseases163
View on UniProt